Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 2, 2003, Pages 323-331

  Simonsen, G S ^a   Smabrekke L ^a   Monnet, D L ^b   Sorensen T L ^b   Moller J K ^b   Kristinsson, K G ^c   Legerqvist Widh, A ^d   Torell, E ^d   Digranes, A ^e   Harthug, S ^e   Sundsfjord, A ^a,f  

^a UNIVERSITY OF TROMSØ   (Norway)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNN   (Norway)

Author keywords

Antimicrobial resistance; Antimicrobial use; Enterococci

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; IMIDAZOLE DERIVATIVE; LINEZOLID; MACROLIDE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG USE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EUROPE; HOSPITAL INFECTION; HOSPITAL PATIENT; INFECTION CONTROL; NONHUMAN; OUTPATIENT; PENICILLIN RESISTANCE; POLICY; PREVALENCE; REVIEW; SPECIES DISTRIBUTION; UNITED STATES;

AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; ICELAND; MICROBIAL SENSITIVITY TESTS; SCANDINAVIA; VANCOMYCIN RESISTANCE;

EID: 0037326934     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg052     Document Type: Review

References (36)

1. Murray, B. E. (1997). Diversity among multidrug-resistant enterococci. Emerging Infectious Diseases 4, 37-47.
2. Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M. et al. (2000). Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. New England Journal of Medicine 343, 1926-32.
3. Murray, B. E. (1990). The life and times of the Enterococcus. Clinical Microbiological Reviews 3, 46-65.
4. Facklam, R. R., Sahm, D. F. & Teixeira, L. M. (1999). Enterococcus. In Manual of Clinical Microbiology, 7th edn (Murray, P., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 297-305. ASM Press, Washington, DC, USA.
5. Wenzel, R. P. & Edmond, M. B. (2001). The impact of hospitalacquired bloodstream infections. Emerging Infectious Diseases 7, 174-7.
6. Huycke, M. M., Sahm, D. F. & Gilmore, M. S. (1998). Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerging Infectious Diseases 4, 239-49.
7. Wade, J. J. (1997). Enterococcus faecium in hospitals. European Journal of Clinical Microbiology and Infectious Diseases 16, 113-9.
8. Atkinson, B. A., Abu-Al-Jaibat, A. & LeBlanc, D. J. (1997). Antibiotic resistance among enterococci isolated from clinical specimens between 1953 and 1954. Antimicrobial Agents and Chemotherapy 41, 1598-600.
9. Dutka Malen, S., Evers, S. & Courvalin, P. (1995). Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. Journal of Clinical Microbiology 33, 24-7.
10. National Committee for Clinical Laboratory Standards. (2001). Performance Standards for Antimicrobial Susceptibility Testing-Eleventh Informational Supplement: M100-S11. NCCLS, Wayne, PA, USA.
11. Patel, R., Uhl, J. R., Kohner, P., Hopkins, M. K. & Cockerill, F. R., III (1997). Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. Journal of Clinical Microbiology 35, 703-7.
12. Dahl, K. H., Lundblad, E. W., Rokenes, T. P., Olsvik, Ø. & Sundsfjord, A. (2000). Genetic linkage of the vanB2 gene cluster to Tn5382 in vancomycin-resistant enterococci and characterization of two novel insertion sequences. Microbiology 146, 1469-79.
13. Simonsen, G. S., Myhre, M. R., Dahl, K. H., Olsvik, Ø. & Sundsfjord A. (2000). Typeability of Tn 1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions. Microbial Drug Resistance 6, 49-57.
14. WHO Collaborating Centre for Drug Statistics Methodology. (1999). Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs). Oslo, Norway.
15. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, 2233-9.
16. Routsi, C., Platsouka, E., Paniara, O., Dimitriadou, E., Saroglou, G., Roussos, C. et al. (2000). Enterococcal infections in a Greek intensive care unit: a 5-y study. Scandinavian Journal of Infectious Diseases 32, 275-80.
17. Noskin, G. A., Peterson, L. R. & Warren, J. R. (1995). Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clinical Infectious Diseases 20, 296-301.
18. Sahm, D. F. (2000). Antimicrobial resistance among enterococci: a view from US clinical laboratories. In Program and Abstracts of the First International ASM Confecerence on Enterococci: Pathogenesis, Biology, and Antibiotic Resistance, Banff, Alberta, Canada, 2000. American Society for Microbiology, Washington, DC, USA.
19. Low, D. E., Keller, N., Barth, A. & Jones, R. N. (2001). Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases 32, Suppl. 2, S133-45.
20. Wilson, W. R., Karchmer, A. W., Dajani, A. S., Taubert, K. A., Bayer, A., Kaye, D. et al. (1995). Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. Journal of the American Medical Association 274, 1706-13.
21. Working party of the British Society for Antimicrobial Chemotherapy. (1998). Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart 79, 207-10.
22. Herman, D. J. & Gerding, D. N. (1991). Antimicrobial resistance among enterococci. Antimicrobial Agents and Chemotherapy 35, 1-4.
23. Simonsen, G. S., Andersen, B. M., Digranes, A., Harthug, S., Jacobsen, T., Lingaas, E. et al. (1998). Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients. Scandinavian Journal of Infectious Diseases 30, 465-8.
24. Torell, E., Cars, O., Olsson-Liljequist, B., Hoffman, B. M., Lindbäck, J. & Burman, L. G. (1999). Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. Journal of Clinical Microbiology 37, 3509-13.
25. Sørensen, T. L., Frimodt-Møller, N. & Espersen, F. (1998). Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995. Clinical Microbiology and Infection 4, 422-30.
26. DANMAP. (2001). DANMAP 2000-Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria From Food Animals, Foods and Humans in Denmark. Danish Veterinary Laboratory, Copenhagen, Denmark.
27. NORM/NORM-VET. (2001). NORM/NORM-VET 2000-Consumption of Antimicrobial Agents and Occurrence of Resistance in Norway. NORM/NORM-VET, Tromsø/Oslo, Norway.
28. Johnson, A. P., Warner, M., Woodford, N., Speller, D. C. & Livermore, D. M. (1998). Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory. British Medical Journal 317, 629-30.
29. Schouten, M. A., Voss, A. & Hoogkamp-Korstanje, J. A. (1999). Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group. Antimicrobial Agents and Chemotherapy 43, 2542-6.
30. Harthug, S., Jureen, R., Mohn, S. C., Digranes, A., Simonsen, G. S., Sundsfjord, A. et al. (2002). The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals. Journal of Hospital Infection 50, 145-54.
31. Wendelbo, Ø., Jureen, R., Eide, G. E., Digranes, A., Langeland, N. & Harthug, S. (2002). Outbreak of infection with high-level gentamicin-resistant Enterococcus faecalis (HLGRE) in a Norwegian Hospital. Clinical Microbiology and Infection, in press.
32. Hodel-Christian, S. L. & Murray, B. E. (1991). Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus facealis and comparison to staphylococcal transposons Tn4001 and Tn4031. Antimicrobial Agents and Chemotherapy 35, 1147-52.
33. Møller, J. K. (1989). Antimicrobial usage and microbial resistance in a university hospital during a seven-year period. Journal of Antimicrobial Chemotherapy 24, 983-92.
34. Monnet, D. L., López-Lozano, J. M., Campillos, P., Burgos, A., Yagüe, A. & Gonzalo, N. (2001). Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clincal Microbiology and Infection 7, Suppl. 5, 29-36.
35. Austin, D. J., Kristinsson, K. G. & Anderson, R. M. (1999). The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences, USA 96, 1152-6.
36. Lipsitch, M., Bergstrom, C. T. & Levin, B. R. (2000). The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proceedings of the National Academy of Sciences, USA 97, 1938-43.